Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
532 | 3 | HYALURONAN//CD44//PROTEOGLYCAN | 20380 |
701 | 2 | PROTEOGLYCAN//HEPARANASE//HEPARAN SULFATE | 13345 |
12183 | 1 | HEPARANASE//CANC VASC BIOL//HEPARANASE INHIBITOR | 954 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | HEPARANASE | authKW | 10582039 | 42% | 79% | 403 |
2 | CANC VASC BIOL | address | 2869193 | 16% | 57% | 152 |
3 | HEPARANASE INHIBITOR | authKW | 535163 | 2% | 90% | 18 |
4 | PI 88 | authKW | 445963 | 2% | 75% | 18 |
5 | HEPARAN SULFATE | authKW | 303700 | 12% | 8% | 113 |
6 | HEPARANASE 1 | authKW | 297309 | 1% | 75% | 12 |
7 | HEPARANASE 2 | authKW | 198210 | 1% | 100% | 6 |
8 | BRUCE R P ORT MED | address | 167388 | 12% | 4% | 117 |
9 | SHARETT | address | 140942 | 1% | 53% | 8 |
10 | CANC VASC BIOL R P ORT | address | 132140 | 0% | 100% | 4 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 2641 | 28% | 0% | 271 |
2 | Biochemistry & Molecular Biology | 728 | 26% | 0% | 247 |
3 | Cell Biology | 683 | 15% | 0% | 146 |
4 | Hematology | 543 | 8% | 0% | 76 |
5 | Medicine, Research & Experimental | 201 | 7% | 0% | 63 |
6 | Immunology | 155 | 8% | 0% | 75 |
7 | Peripheral Vascular Diseases | 141 | 4% | 0% | 41 |
8 | Pathology | 95 | 3% | 0% | 33 |
9 | Urology & Nephrology | 48 | 3% | 0% | 27 |
10 | Biophysics | 40 | 3% | 0% | 33 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC VASC BIOL | 2869193 | 16% | 57% | 152 |
2 | BRUCE R P ORT MED | 167388 | 12% | 4% | 117 |
3 | SHARETT | 140942 | 1% | 53% | 8 |
4 | CANC VASC BIOL R P ORT | 132140 | 0% | 100% | 4 |
5 | DRUG DESIGN GRP | 99675 | 1% | 23% | 13 |
6 | MOL ONCOGENESIS GRP | 99105 | 0% | 100% | 3 |
7 | THROMBOSIS HEMOSTASIS UNIT | 84559 | 2% | 12% | 22 |
8 | CANC VASC BIOL GRP | 81073 | 1% | 27% | 9 |
9 | CANC MOL IMMUNOL GRP | 66070 | 0% | 100% | 2 |
10 | CANC VASC | 66070 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NEOPLASIA | 4230 | 2% | 1% | 15 |
2 | GLYCOBIOLOGY | 1622 | 1% | 0% | 12 |
3 | MATRIX BIOLOGY | 1503 | 1% | 1% | 8 |
4 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 818 | 0% | 1% | 3 |
5 | INVASION & METASTASIS | 673 | 0% | 1% | 3 |
6 | CANCER RESEARCH | 614 | 3% | 0% | 28 |
7 | ADVANCES IN ENZYME REGULATION | 493 | 0% | 1% | 3 |
8 | ONCOTARGET | 492 | 2% | 0% | 16 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 447 | 5% | 0% | 49 |
10 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 427 | 1% | 0% | 6 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPARANASE | 10582039 | 42% | 79% | 403 | Search HEPARANASE | Search HEPARANASE |
2 | HEPARANASE INHIBITOR | 535163 | 2% | 90% | 18 | Search HEPARANASE+INHIBITOR | Search HEPARANASE+INHIBITOR |
3 | PI 88 | 445963 | 2% | 75% | 18 | Search PI+88 | Search PI+88 |
4 | HEPARAN SULFATE | 303700 | 12% | 8% | 113 | Search HEPARAN+SULFATE | Search HEPARAN+SULFATE |
5 | HEPARANASE 1 | 297309 | 1% | 75% | 12 | Search HEPARANASE+1 | Search HEPARANASE+1 |
6 | HEPARANASE 2 | 198210 | 1% | 100% | 6 | Search HEPARANASE+2 | Search HEPARANASE+2 |
7 | HUMAN HEPARANASE | 132140 | 0% | 100% | 4 | Search HUMAN+HEPARANASE | Search HUMAN+HEPARANASE |
8 | RONEPARSTAT | 132140 | 0% | 100% | 4 | Search RONEPARSTAT | Search RONEPARSTAT |
9 | PICHIA HOLSTII | 99105 | 0% | 100% | 3 | Search PICHIA+HOLSTII | Search PICHIA+HOLSTII |
10 | PG545 | 88091 | 0% | 67% | 4 | Search PG545 | Search PG545 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |